The Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design

The Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria Synthesis and Structure–Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold Discovery of benzimidazole derivatives as modulators of mitochondrial function: A potential treatment for Alzheimer's disease Identification of a Novel Benzoxazolone Derivative as a Selective, Orally Active 18 kDa Translocator Protein (TSPO) Ligand 1,1′-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: A new potential copper chelator agent for neuroprotection in Alzheimer’s disease. Its comparative effects with clioquinol on rat brain copper distribution Transient Receptor Potential Ankyrin 1 (TRPA1) Channel as Emerging Target for Novel Analgesics and Anti-Inflammatory Agents Drug excretion mediated by a new prototype of polyspecific transporter Structure-based drug designing for N-methyl-D-aspartate receptor: Link between neurodegenerative disease and glioblastoma Synthesis and Biological Evaluation of 3,7-Diazabicyclo[4.3.0]nonan-8-ones as Potential Nootropic and Analgesic Drugs